Kate Henshaw, a veteran actress, has been vocal about the importance of women's health and wellness, particularly in addressing menopausal challenges. She recently spoke at the launch of Efamol Evening Primrose Oil (EPO) in Lagos, where she emphasized the need for women to take control of their health. Henshaw, who is also a celebrity activist, noted that her approach to health has always gone beyond appearance, and that maintaining vitality requires intentional decisions rooted in understanding the body. She shared her personal experience with menopause, stating that she only realized the symptoms and effects after age 50.
The event, hosted by the Association of Community Pharmacists of Nigeria (ACPN), Lagos State chapter, brought together leading pharmacists, healthcare professionals, and industry stakeholders. Ibukun Tola-Ogunyemi, managing director of Pontisalus Pharmacy, highlighted the growing demand for evidence-based wellness solutions among Nigerian consumers. She noted that Efamol EPO provides pharmacists with a credible option to support patients more effectively, thanks to its high Gamma Linolenic Acid (GLA) content and strong clinical backing.
Mosunmola Dosumu, founder of Nigeria's first menopause-focused support initiative, emphasized that menopause is not a condition to fear, but a natural phase that can be properly managed with the right knowledge and support. She explained that nutritional interventions such as essential fatty acids play a significant role in improving skin elasticity, reducing dryness, and alleviating discomfort associated with hormonal changes.
Ogheneochuko Omaruaye, CEO of New Heights Pharmaceuticals Limited, assured stakeholders and consumers of the product's availability and accessibility nationwide. He emphasized that Efamol meets international quality standards and has been carefully introduced into the Nigerian market to address a growing need for clinically proven wellness solutions.
Kate Henshaw's advocacy for women's health and wellness is a timely reminder of the need for Nigerian women to prioritize their health. The launch of Efamol EPO is a step in the right direction, providing a credible and evidence-based solution for managing menopausal challenges. However, the reality is that many Nigerian women still lack access to quality healthcare and wellness solutions. It is imperative that healthcare providers and pharmaceutical companies prioritize the needs of Nigerian women, particularly in the areas of menopause management and overall wellness. By doing so, they can help reduce the burden of menopausal symptoms and improve the overall health and well-being of Nigerian women.
